Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 1/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.46 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.43 |
| ▸ | ABL1 | P00519 | 2/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.41 |
| ▸ | BCR | P11274 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.40 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CYP2C8 | P10632 | 2/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.40 |
| ▸ | CYP4B1 | P13584 | 2/20 | 0.40 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.40 |
| ▸ | CYP3A5 | P20815 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12865663 | 0.88 | PDK2 (0.46) | HSD17B1HSD17B2PDK2ABL1ABCB1 | |
| SCHEMBL12865654 | 0.88 | PDK2 (0.46) | HSD17B1HSD17B2PDK2ABL1ABCB1 | |
| SCHEMBL12865657 | 0.85 | PDK2 (0.36) | HSD17B1HSD17B2PDK2ABL1ABCB1 | |
| SCHEMBL12393756 | 0.83 | PDK2 (0.59) | PDK2ABL1ABCB1BCRSMN1; SMN2 | |
| SCHEMBL12056905 | 0.83 | PDK2 (0.49) | HSD17B1HSD17B2PDK2CYP1A2CYP2D6 | |
| SCHEMBL12865633 | 0.81 | HSD17B1 (0.50) | HSD17B1HSD17B2PDK2ABL1ABCB1 | |
| SCHEMBL29044686 | 0.80 | METAP1 (0.46) | KDM4EELANEMAPK1CA1CA2 | |
| SCHEMBL14600344 | 0.78 | PDK2 (0.44) | PDK2ABL1ABCB1BCRSMN1; SMN2 | |
| SCHEMBL3296834 | 0.77 | PDK2 (0.49) | PDK2ABL1ABCB1BCRSMN1; SMN2 | |
| SCHEMBL16295947 | 0.77 | PDK2 (0.49) | PDK2ABL1ABCB1BCRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7883786-B2 | highly efficient and highly luminescent optical power and is superior in durability | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-7883786-B2 | highly efficient and highly luminescent optical power and is superior in durability | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CANON KABUSHIKI KAISHA (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | CANON KABUSHIKI KAISHA (JP) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080297034-A1 | BIPHENYL DERIVATIVE AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME | LEF1, CYP1B1, ESR1 | HSD17B1 874/4885HSD17B2 838/4885PDK2 1367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.